Healthcare, Pharma & Life Sciences

Lee Equity Invests in Marwood Group, Names Ex-EY Exec CEO

Image
Lee Equity Invests in Marwood Group, Names Ex-EY Exec CEO

New York – September 15, 2026 -- Marwood Group, a healthcare-focused advisory and consulting firm, has secured a strategic investment from Lee Equity Partners to fund acquisitions and senior team hires as it expands beyond its core policy and reimbursement advisory business.

Chris Librizzi departs EY-Parthenon to take Marwood's CEO role

Librizzi joins Marwood after five years leading EY-Parthenon's US strategy consulting business. He previously built and led EY's firmwide corporate strategy function and sat on the company's US Board and Executive Committee. At EY-Parthenon, he oversaw diversification into new customer segments and offerings, developed new products and client solutions, and led senior hires and acquisition integrations.

JAANUU, LA Kings Expand Partnership With Healthcare Night

Image
JAANUU, LA Kings Expand Partnership With Healthcare Night

El Segundo – September 15, 2026 -- JAANUU, the physician-founded medical apparel brand, has expanded its sponsorship deal with the Los Angeles Kings for the 2026-27 NHL season, adding a dedicated Healthcare Professionals Appreciation Night to the partnership.

Kings and JAANUU add themed game night on October 13

The expanded agreement, brokered by AEG Global Partnerships, will see the LA Kings host the Edmonton Oilers at Crypto.com Arena on Tuesday, October 13 at 7:30 p.m. for the inaugural Healthcare Professionals Appreciation Night presented by JAANUU. Every ticketed guest at the game will receive a co-branded foam puck, while JAANUU will run interactive activations, giveaways and contests throughout the arena.

CIA, TRA Merge Radiology Networks to Form Affiliated Radiology

Image
CIA, TRA Merge Radiology Networks to Form Affiliated Radiology

Denver and Tacoma, Wash. – September 15, 2026 -- Colorado Imaging Associates (CIA) and TRA Medical Imaging (TRA) have formed Affiliated Radiology, a physician-led organization combining nearly 200 radiologists across the Pacific Northwest and Rocky Mountain regions under a shared technology and operational platform.

New entity aggregates PACS, AI infrastructure and radiologist capacity across two regional practices

Affiliated Radiology will centralize PACS, AI-supported workflow tools, and clinical diagnostic AI across partnering organizations. The structure is designed to pool technology investment and purchasing power, lowering per-partner costs for AI-supported pre-drafting and other infrastructure while allowing practices to retain local ownership and physician governance.

Global Action Grant Backs Smoking Cessation for Kidney Donors

Image
Global Action Grant Backs Smoking Cessation for Kidney Donors

New York – September 15, 2026 -- Global Action to End Smoking has issued a grant to The University of Chicago to expand smoking cessation and tobacco harm reduction support for prospective living kidney donors, aiming to increase the pool of eligible donors amid a severe organ shortage.

Kidney demand vastly outstrips supply as nearly 4,000 died waiting in 2023

More than 109,000 people are on the U.S. organ transplant waiting list, with roughly 95,000 awaiting a kidney, according to the U.S. Health Resources and Services Administration. The Association of Organ Procurement Organizations reported that nearly 4,000 individuals died in 2023 while waiting for a kidney donation. Because donation centers typically require donors to abstain from smoking before surgery due to elevated complication risks, tobacco use disqualifies otherwise willing living donors.

NAMI CEO Gillison Named to NPT 2026 Power & Influence Top 50

Image
NAMI CEO Gillison Named to NPT 2026 Power & Influence Top 50

Arlington, Va. – September 15, 2026 -- Daniel H. Gillison, Jr., CEO of the National Alliance on Mental Illness (NAMI), has been named to The NonProfit Times 2026 Power & Influence Top 50 list, an honor tied to a $59 million gift secured from donor MacKenzie Scott. Gillison will be recognized at the 20th Power & Influence Top 50 Gala on September 17 at the National Press Club in Washington, D.C.

NPT credits Gillison with modernizing NAMI's crisis infrastructure

The NonProfit Times stated that Gillison "modernized the nation's largest grassroots mental health nonprofit, built cross-sector coalitions and secured investments from donors, including MacKenzie Scott, who gifted $59 million." Under his leadership, NAMI launched the National Collaborative for Crisis Systems Innovation, a hub designed to align and strengthen behavioral health crisis care, including the 988 Suicide and Crisis helpline program.

Caloric Restriction Cuts DNA Mutation Rates Across Mouse Genome, Study Finds

Image
Caloric Restriction Cuts DNA Mutation Rates Across Mouse Genome, Study Finds

New York City – September 15, 2026 -- Mice fed 30 percent fewer calories than their normal intake showed reduced levels of DNA mutations across multiple tissues, according to a study published September 9 in Cell by researchers at NYU Langone Health and University Hospitals Cleveland.

Researchers Measure Genome-Wide Mutation Reduction for the First Time

The study is the first to quantify how caloric restriction affects mutation patterns across a large portion of the genome, rather than in single genes as prior research had done. Using advanced DNA sequencing technology, the team tracked both substitution mutations, where one DNA letter replaces another, and insertion-deletion mutations, where DNA letters are added or removed.

The research was conducted in collaboration with the University of Texas Southwestern Medical Center and the National Institutes of Health.

DCD Heart Transplants Expand in US Without Worse Outcomes, Study Finds

Image
DCD Heart Transplants Expand in US Without Worse Outcomes, Study Finds

Washington – September 15, 2026 -- Donation after circulatory death (DCD) heart transplantation expanded rapidly across the United States between 2019 and 2024 without any measurable decline in early clinical outcomes, according to research published in the September 2026 issue of the Journal of Cardiac Failure (JCF).

Registry data on 1,489 patients show no rise in graft failure or mortality

Investigators analyzed U.S. registry data covering 1,489 adult DCD heart transplant recipients, comparing the early adoption period of 2019-2021 with the national expansion period of 2022-2024. The analysis found no significant differences in one-year graft failure, mortality, need for renal replacement therapy, re-transplantation or hospital length of stay between the two periods. Outcomes remained consistent even among higher-risk recipients, as DCD transplantation spread to a growing number of transplant centers nationwide.

NovaOne Launches Unified Platform to Cut Behavioral Health Point-Solution Costs

Image
NovaOne Launches Unified Platform to Cut Behavioral Health Point-Solution Costs

Newark, N.J. – September 15, 2026 -- NovaOne has launched a modular healthcare platform that merges preventive, curative and specialty behavioral health services into a single contract, aiming to eliminate the fragmented vendor stacks that health plans and employers have relied on for years.

Platform cuts time-to-care from 50 days to under five

Members are screened across more than 15 clinical risk areas and routed to in-network providers proven effective for their specific conditions, reaching evidence-based care in under five days on average, compared with a national average exceeding 50 days.

ABMS Convenes 400+ Healthcare Leaders at Sept. 16-18 Certification Conference

Image
ABMS Convenes 400+ Healthcare Leaders at Sept. 16-18 Certification Conference

Chicago – September 15, 2026 -- The American Board of Medical Specialties (ABMS) will gather more than 400 healthcare professionals at the Loews O'Hare Hotel in Rosemont, Illinois, from September 16-18 for its annual conference on physician board certification.

Conference agenda spans 40 breakout sessions and AI-focused workforce debates

The three-day program includes two plenary sessions, 40 breakout sessions, one Sponsor Spotlight, four Exhibitor Showcases, and a 40-poster session. Core topics cover artificial intelligence in medicine, professionalism standards, innovation assessment methods, competency-based medical education, and structural shifts in the US physician workforce.

Nature Study Validates PLA2G2D as New Checkpoint Beating PD-1 Resistance

South San Francisco, Calif. – September 15, 2026 -- Apeximmune Therapeutics said a peer-reviewed study published in Nature independently validates PLA2G2D as a novel immune checkpoint capable of overcoming resistance to anti-PD-1 cancer therapies, with the company's lead antibody AI-306 targeting an IND filing in the second quarter of 2027.

Two independent research teams identified the same target through different methods

Apeximmune's computational screen of more than 9,000 primary tumor samples from The Cancer Genome Atlas ranked PLA2G2D as its top novel checkpoint candidate, ahead of PD-1 and CTLA-4 in the same analysis. Working separately and without knowledge of Apeximmune's program, researchers at Erasmus University Medical Center in Rotterdam used spatial proteogenomic analysis of melanoma patient samples with divergent outcomes and arrived at PLA2G2D as a top hit in dendritic cell and macrophage populations linked to poorer prognosis.